Pathogenic mutations in PRPH2 can lead to a wide spectrum of IRD presentations, including retinitis pigmentosa (RP), cone/cone–rod dystrophy (CD/CRD), and macular dystrophy (MD), as previously reported [12,13]. This evidence concerns the gene PRPH2 and retinitis pigmentosa 1.